Le Yu

Peking University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Le Yu is a pioneering urologic oncologist whose research has fundamentally advanced the surgical management of renal cell carcinoma (RCC) with tumor thrombus. His landmark work, a large-scale retrospective study from a high-volume center, demonstrated that segmental resection of the inferior vena cava (IVC) is both safe and feasible for these complex patients. This contribution, already cited twice in 2025, provides critical evidence that challenges traditional surgical boundaries, offering a potentially curative option for cases previously deemed inoperable. Dr. Yu’s expertise lies in refining high-risk surgical techniques and improving perioperative outcomes for advanced RCC. His research has direct, life-saving implications for patients with tumor thrombus extension into the IVC, a condition associated with poor prognosis. By systematically evaluating surgical safety and oncologic efficacy, Dr. Yu has established a new standard of care at his high-volume center, influencing clinical guidelines and inspiring further prospective studies. His work exemplifies the translation of meticulous surgical science into tangible patient benefit, marking him as a leading figure in the field of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Segmental Resection of the Inferior Vena Cava is Safe and Feasible for Patients with Renal Cell Carcinoma with Tumor Thrombus: A Large-Scale Retrospective Study from a High-Volume Center
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Peking University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago